Align Technology, Inc. (ALGN) rated Buy with price target $24 by Brean Murray
Brean Murray rated Buy Align Technology, Inc. (NASDAQ: ALGN) on 01/28/2010. Previously Brean Murray rated Buy Align Technology, Inc. (NASDAQ: ALGN) on
02/03/2009., when the stock price was $8.17. Since then, Align Technology, Inc. has gained 564.50% as of 04/10/2015's recent price of $54.29. If you would have followed the previous Brean Murray's recommendation on ALGN, you would have gained 564.5% of your investment in 2257 days.
Align Technology Inc. designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. The System corrects malocclusion using a series of clear, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, the System significantly reduces the aesthetic and other limitations associated with braces. The Invisalign System also offers orthodontists a new means of carrying out their diagnosis and treatment planning processes.
Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients.
Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion.
Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage.
Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients.
Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.